流通市值:17.52亿 | 总市值:19.35亿 | ||
流通股本:9269.58万 | 总股本:1.02亿 |
报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
公司类型 | 通用 | 通用 | 通用 | 通用 |
流动资产: | ||||
货币资金 | 288,515,578.55 | 164,955,448.39 | 189,640,236.23 | 227,235,990.98 |
结算备付金 | - | 0 | - | - |
拆出资金 | - | 0 | - | - |
衍生金融资产 | - | 0 | - | - |
应收票据及应收账款 | 222,167,331.42 | 208,058,334.87 | 195,896,733.82 | 189,738,808.41 |
其中:应收票据 | 3,975,775.24 | 3,971,711.45 | 4,693,383.1 | 11,201,817.94 |
应收账款 | 218,191,556.18 | 204,086,623.42 | 191,203,350.72 | 178,536,990.47 |
应收款项融资 | 99,505,392.03 | 99,280,047.39 | 105,185,853.41 | 83,693,361.71 |
预付款项 | 2,609,486.78 | 2,677,995.59 | 4,460,205.28 | 3,127,770.12 |
应收保费 | - | 0 | - | - |
应收分保账款 | - | 0 | - | - |
应收分保合同准备金 | - | 0 | - | - |
其他应收款合计 | 3,632,097.45 | 4,517,377.3 | 3,625,482.86 | 3,545,049.06 |
其中:应收利息 | - | 0 | - | - |
应收股利 | - | 0 | - | - |
买入返售金融资产 | - | 0 | - | - |
存货 | 156,579,255.45 | 161,566,578.43 | 160,220,229.18 | 167,651,875.07 |
合同资产 | - | 0 | - | - |
一年内到期的非流动资产 | - | 0 | - | - |
其他流动资产 | 30,118,100.45 | 31,680,102.7 | 22,012,251.37 | 16,664,264.63 |
流动资产平衡项目 | 0 | 0 | 0 | 0 |
流动资产合计 | 803,127,242.13 | 772,735,884.67 | 741,040,992.15 | 751,657,119.98 |
非流动资产: | ||||
发放委托贷款及垫款 | - | 0 | - | - |
债权投资 | - | 0 | - | - |
其他债权投资 | - | 0 | - | - |
长期应收款 | - | 0 | - | - |
长期股权投资 | - | 0 | - | - |
其他权益工具投资 | - | 0 | - | - |
其他非流动金融资产 | - | 0 | - | - |
投资性房地产 | 5,507,901.11 | 5,662,537.64 | 5,817,174.17 | 5,971,810.7 |
固定资产 | 30,430,153.98 | 29,146,406.21 | 29,636,828.31 | 30,362,112.29 |
在建工程 | 35,724,969.26 | 33,347,607.82 | 32,882,887.42 | 31,032,978.73 |
生产性生物资产 | - | 0 | - | - |
油气资产 | - | 0 | - | - |
使用权资产 | 3,842,401.33 | 5,975,183.23 | 8,100,878.02 | 10,169,875.93 |
无形资产 | 6,666,647.11 | 4,895,076.9 | 4,850,622.6 | 5,051,677.03 |
开发支出 | - | 0 | - | - |
商誉 | - | 0 | - | - |
长期待摊费用 | 5,468,258.13 | 7,297,150.67 | 8,921,596.58 | 8,852,221.03 |
递延所得税资产 | 5,279,398.01 | 5,391,295.26 | 5,675,285.11 | 5,703,621.08 |
其他非流动资产 | 14,948,181.77 | 12,107,952.55 | 9,833,819.08 | 10,630,226.17 |
非流动资产平衡项目 | 0 | 0 | 0 | 0 |
非流动资产合计 | 107,867,910.7 | 103,823,210.28 | 105,719,091.29 | 107,774,522.96 |
资产平衡项目 | 0 | 0 | 0 | 0 |
资产总计 | 910,995,152.83 | 876,559,094.95 | 846,760,083.44 | 859,431,642.94 |
流动负债: | ||||
短期借款 | 52,930,000 | 59,940,000 | 50,628,000 | 41,134,000 |
向中央银行借款 | - | 0 | - | - |
吸收存款及同业存放 | - | 0 | - | - |
拆入资金 | - | 0 | - | - |
交易性金融负债 | - | 0 | - | - |
衍生金融负债 | - | 0 | - | - |
应付票据及应付账款 | 139,993,819.95 | 126,399,594.26 | 120,495,904.58 | 124,269,178.23 |
其中:应付票据 | 16,908,917.3 | 21,772,918.77 | 17,860,721.26 | 18,266,535.65 |
应付账款 | 123,084,902.65 | 104,626,675.49 | 102,635,183.32 | 106,002,642.58 |
预收款项 | - | 0 | - | - |
合同负债 | 343,197.49 | 876,649.14 | 188,832.71 | 496,113.39 |
卖出回购金融资产款 | - | 0 | - | - |
应付手续费及佣金 | - | 0 | - | - |
应付职工薪酬 | 8,532,001.47 | 4,787,181.93 | 4,949,005.26 | 4,338,026.94 |
应交税费 | 10,124,726.16 | 5,950,347.56 | 5,256,359.13 | 2,330,554.42 |
其他应付款合计 | 2,048,686.79 | 1,511,956.58 | 1,896,170.99 | 1,515,942.05 |
其中:应付利息 | - | 0 | - | - |
应付股利 | - | 0 | - | - |
应付分保账款 | - | 0 | - | - |
保险合同准备金 | - | 0 | - | - |
代理买卖证券款 | - | 0 | - | - |
代理承销证券款 | - | 0 | - | - |
一年内到期的非流动负债 | 4,186,593.35 | 6,593,594.98 | 8,955,939.27 | 9,582,900.01 |
其他流动负债 | 30,611,313.65 | 30,532,644.31 | 21,546,074.17 | 16,011,456.74 |
流动负债平衡项目 | 0 | 0 | 0 | 0 |
流动负债合计 | 248,770,338.86 | 236,591,968.76 | 213,916,286.11 | 199,678,171.78 |
非流动负债: | ||||
长期借款 | - | 0 | - | - |
应付债券 | - | 0 | - | - |
优先股 | - | 0 | - | - |
永续债 | - | 0 | - | - |
租赁负债 | 59,389.95 | 88,563.26 | 118,788.26 | 1,776,622.15 |
长期应付款 | - | 0 | - | - |
长期应付职工薪酬 | - | 0 | - | - |
预计负债 | 20,140,410.13 | 19,689,504.12 | 18,980,363.81 | 18,939,816.95 |
递延收益 | 2,862,923.52 | 3,018,987.96 | 3,175,052.64 | 3,331,117.32 |
递延所得税负债 | 1,277,696.06 | 2,010,042.25 | 2,411,598.89 | 2,659,452.07 |
其他非流动负债 | - | 0 | - | - |
非流动负债平衡项目 | 0 | 0 | 0 | 0 |
非流动负债合计 | 24,340,419.66 | 24,807,097.59 | 24,685,803.6 | 26,707,008.49 |
负债平衡项目 | 0 | 0 | 0 | 0 |
负债合计 | 273,110,758.52 | 261,399,066.35 | 238,602,089.71 | 226,385,180.27 |
所有者权益(或股东权益): | ||||
实收资本(或股本) | 102,385,812 | 102,385,812 | 102,385,812 | 102,385,812 |
其他权益工具 | - | 0 | - | - |
优先股 | - | 0 | - | - |
永续债 | - | 0 | - | - |
资本公积 | 326,428,607.24 | 323,225,287.07 | 323,225,287.07 | 323,225,287.07 |
减:库存股 | - | 0 | - | - |
其他综合收益 | 2,038,160.04 | 3,165,903.73 | 2,219,496.83 | 1,979,254.55 |
专项储备 | - | 0 | - | - |
盈余公积 | 75,987,440.88 | 69,694,197.92 | 69,694,197.92 | 69,694,197.92 |
一般风险准备 | - | 0 | - | - |
未分配利润 | 131,044,374.15 | 116,688,827.88 | 110,633,199.91 | 135,761,911.13 |
归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
归属于母公司股东权益合计 | 637,884,394.31 | 615,160,028.6 | 608,157,993.73 | 633,046,462.67 |
少数股东权益 | - | 0 | - | - |
股东权益平衡项目 | 0 | 0 | 0 | 0 |
股东权益合计 | 637,884,394.31 | 615,160,028.6 | 608,157,993.73 | 633,046,462.67 |
负债和股东权益合计 | 910,995,152.83 | 876,559,094.95 | 846,760,083.44 | 859,431,642.94 |
公告日期 | 2024-03-23 | 2023-10-28 | 2023-08-30 | 2023-04-25 |
审计意见(境内) | 标准无保留意见 |